Stefan Goemaere
Show
Sort by
-
A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis
-
Proandrogenic and antiandrogenic progestins in transgender youth : differential effects on body composition and bone metabolism
-
Predicting mortality and incident immobility in older Belgian men by characteristics related to sarcopenia and frailty
-
Bone turnover in young adult men : cross-sectional determinants and associations with prospectively assessed bone loss
-
Atypical femoral fractures : three cases and a review of literature
-
Vitamin D level and calcium intake are related to PTH levels but not bone turnover in healthy young men at the age of peak bone mass
-
Smoking in men after peak bone mass acquisition is associated with faster trabecular bone loss
-
BPS804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta : results of a randomized phase 2a trial
-
Patients' preferences for anti-osteoporosis drug treatment : a cross-European discrete choice experiment
-
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy : a randomised, open-label, phase 3 trial